[HTML][HTML] Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: a multicenter, randomized, double-blind, placebo-controlled trial

K Miki, R Maekura, N Nagaya, M Nakazato, H Kimura… - PloS one, 2012 - journals.plos.org
Background Pulmonary cachexia is common in advanced chronic obstructive pulmonary
disease (COPD), culminating in exercise intolerance and a poor prognosis. Ghrelin is a novel …

The Recovery of Mycobacterium avium-intracellulare Complex (MAC) from the Residential Bathrooms of Patients with Pulmonary MAC

…, A Hirotani, K Yoshimura, M Miki… - Clinical Infectious …, 2007 - academic.oup.com
The distribution of Mycobacterium avium-intracellulare complex (MAC) in residences was
examined. MAC was only recovered from bathrooms but not from other sites of residences. …

Human airway trypsin-like protease stimulates human bronchial fibroblast proliferation in a protease-activated receptor-2-dependent pathway

…, Y Nakaya, H Maezawa, M Miki… - … of Physiology-Lung …, 2006 - journals.physiology.org
Human airway trypsin-like protease (HAT) was isolated from airway secretions and localized
to bronchial epithelial cells by immunohistochemistry. In the present study, we examined …

[PDF][PDF] Effect of human airway trypsin-like protease on intracellular free Ca^ 2^+ concentration in human bronchial epithelial cells

M Miki, Y Nakamura, A Takahashi, Y Nakaya… - Journal of Medical …, 2003 - core.ac.uk
It has been shown that human airway trypsin-like protease (HAT) is localized in human
bronchial epithelial cells (HBEC), and trypsin activates protease-activated receptor-2 (PAR-2). …

[HTML][HTML] First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease

…, T Matsuki, H Kagawa, K Tsujino, M Miki, K Miki… - Scientific Reports, 2021 - nature.com
The combination of rifamycin (RFP), ethambutol (EB), and macrolides is currently the
standard regimen for treatment of Mycobacterium avium complex pulmonary disease (MAC-PD). …

[HTML][HTML] Long-Term Treatment Outcome of Progressive Mycobacterium avium Complex Pulmonary Disease

…, K Tsujino, K Yoshimura, M Miki, K Miki… - Journal of clinical …, 2020 - mdpi.com
Background: Multidrug therapy is essential for preventing respiratory failure in patients with
highly progressive Mycobacterium avium complex pulmonary disease (MAC-PD). However, …

Personalized pulmonary rehabilitation and occupational therapy based on cardiopulmonary exercise testing for patients with advanced chronic obstructive pulmonary …

…, T Hiraga, K Miki, S Kitada, M Miki… - … journal of chronic …, 2015 - Taylor & Francis
Take-home summary Personalized pulmonary rehabilitation including occupational therapy
improves the prognosis of patients with advanced COPD. Purpose We previously reported …

[HTML][HTML] Comparative genomic analysis of Mycobacterium intracellulare: implications for clinical taxonomic classification in pulmonary Mycobacterium avium …

Y Tateishi, Y Ozeki, A Nishiyama, M Miki, R Maekura… - BMC microbiology, 2021 - Springer
Background Mycobacterium intracellulare is a representative etiological agent of emerging
pulmonary M. avium-intracellulare complex disease in the industrialized countries worldwide. …

Levels of antibody against glycopeptidolipid core as a marker for monitoring treatment response in Mycobacterium avium complex pulmonary disease: a prospective …

…, R Maekura, K Yoshimura, K Miki, M Miki… - Journal of clinical …, 2017 - Am Soc Microbiol
The diagnosis of Mycobacterium avium complex pulmonary disease (MAC-PD) is sometimes
complicated and time-consuming. A serodiagnostic kit that measures the serum levels of …

Serum antibody profiles in individuals with latent Mycobacterium tuberculosis infection

…, Y Tateishi, Y Ozeki, T Fujicawa, M Miki… - Microbiology and …, 2019 - Wiley Online Library
One‐third of the world's humans has latent tuberculosis infection (LTBI), representing a large
pool of potentially active TB. Recent LTBI carries a higher risk of disease progression than …